Summary
The human being is one of the least fertile among the mammals, despite the alarming scene of global overpopulation. Human fertility is certainly on the decline. There are several historical, demographic, geographic, social, genetic and environmental factors contributing to the decline. Medical drugs do contribute to a decline in the fertility of some couples. Iatrogenic causes of medical illness are increasing the world over. The chapter gives an overview of medical drugs impairing fertility in men and women. Drugs may impair male fertility by interfering with spermatogenesis, sperm motility, or by interfering with the fertilising capacity of spermatozoa. Female fertility may be compromised by impairing oogenesis, ovulation, or through the suppression of ovarian function. The incidence of acid peptic disease and hypertension is increasing globally, even amongst young men and women. Drugs used to treat these conditions impair sexual function and fertility. Several drugs used to treat connective tissue diseases affect gonadal function. Many childhood/early adulthood malignancies are either treatable or curable today. Chemotherapeutic agents, while very effective in managing malignancies, often lead to impairment of fertility. Use, and abuse, of antibiotics and antibacterials have increased phenomenally. These drugs can impair fertility, albeit temporarily. Several drugs used to treat mental illness impair sexual function and fertility. Fertility impaired by medical drugs is often reversible except when associated with antimitotic drugs. Judicious use of drugs, and use of alternate drugs if necessary, would help in the restoration of sexual function and fertility in many couples.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Auger, J., Kunstmann, J.M., Czyglik, F., and Jouannet, P. (1995) Decline in semen quality among fertile men in Paris during the past 20 years, N. Engl. J. Med. 332, 281-285.
Barnes, A.B., Colton, T., Gunderson, J., Noller, K.L., Tilley, B.C., Strama, T., Townsend, D.E., Hatab, P., and O’Brien, P.C. (1980) Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol, N. Engl. J. Med. 302, 609-613.
Brown, L.M., Pottern, L.M., and Hoover, R.N. (1986) Prenatal and perinatal risk factors for testicular cancer, Cancer Res. 46, 4812-4816.
Byrne, J., Fears, T.R., Gail, M.H., Pee, D., Connelly, R.R., Austin, D.F., Holmes, G.F., Holmes, F.F., Latourette, H.B/, and Meigs, J.W. (1992) Early menopause in long term survivors of cancer during adolescence, Am. J. Obstet. Gynaecol. 166, 788-793.
Carlsen, E., Giwercman, A., Keiding, N., and Skakkebaek, N.E. (1992) Evidence for decreasing quality of semen during past 50 years, BMJ 305, 609-613.
Chermesh, I., and Eliakim, R. (2004) Mesalazine-induced reversible infertility in a young male, Dig. Liver. Dis. 36, 551-552.
Damani, M.N., Masters, V., Meng, M.V., Burgess, C., Turek, P., and Oates, R.D. (2002) Postchemotherapy Ejaculatory Azoospermia: Fatherhood With Sperm From Testis Tissue With Intracytoplasmic Sperm Injection, J. Clin. Oncol. 20, 930-936.
DeCherney, A.H., and Naftolin, F. (1988) Diethylstilbestrol: Effect on Fertility, In: S.J. Behrman, R.W. Kistner and G.W. Patton (Eds) Progress in Infertility, 3rd Edition. Boston: Little, Brown and Co., pp. 227-236.
Diethylstilbestrol: Effect on Fertility, In: S.J., Behrman, R.W. Kistner and G.W. Patton (Eds) Progress in Infertility, 3rd Edition. Boston: Little, Brown and Co., pp. 227-236
Driscoll, S.G., and Taylor, S.H. (1980) Effects of prenatal maternal oestrogen on the male urogenital system, Obstet. Gynecol. 56, 537-542.
Gill, W.B., Schumacher, G.F.B., Bibbo, M., Straus, F.H. II, and Schoenberg, H.W. (1979) Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities, J. Urol. 122, 36-39.
Howell, S., and Shalet, S. (1998) Gonadal damage from chemotherapy and radiotherapy, Endocrinol. Metab. Clin. North. Am. 27, 927-943.
Howell, S.J., Radford, J.A., Ryder, W.D., and Shalet, S.M. (1999) Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency, J. Clin. Oncol. 17, 1493-1498.
Karande, V.C., Lester, R.G., Muasher, S.J., Jones, D.L., Acosta, A.A., and Jones, H.W. Jr. (1990) Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer? Fertil. Steril. 54, 287-291.
Kaufman, R.H., Adam, E., Noller, K., Irwin, J.F., and Gray, M. (1986) Upper genital tract changes and infertility in diethylstilbestrol-exposed women, Am. J. Obstet. Gynecol. 154, 1312-1318.
Larsen, E.C., Muller, J., Schmiegelow, K., Rechnitzer, C., and Andersen, A.N. (2003) Reduced ovarian function in long term survivors of radiation and chemotherapy treated childhood cancer, J. Clin. Endocrinol. Metab. 88, 5307-5314.
Leary, F.J., Ressenguie, L.J., Kurland, L.T., O’Brien, P.C., Emslander, R.F., and Noller, K.L. (1984) Males exposed in utero to diethylstilbestrol, J. Am. Med. Assoc. 252, 2984-2989.
Mehta, R.H., and Kumar, T.C.A. (1999) Anatomy and Physiology of the male reproductive system, in N. Pandiyan (ed.) Handbook of Andrology, First edition, T R publishers, ; Chennai, pg 1-17.
Mendonca, L.L., Khamashta, M.A., Nelson-Piercy, C., Hunt, B.J., and Hughes, G.R. (2000) Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility, Rheumatology 39, 880-882.
Pandiyan, N. (2000) Medical management of male infertility, Reproductive Biomedicine Online 1, 13 - 16.
Pandiyan, N., and Jequier, A.M. (1996) Mitotic chromosomal anomalies among 1210 infertile men, Hum. Reprod. 11, 2604-2608.
Pont, J., and Albrecht, W. (1997) Fertility after chemotherapy for testicular germ cell cancer, Fertil. Steril. 68, 1-5.
Ral, D., Manor, M., Cohen Dayag, A., Tur-Kaspa, I., Ben-Shlomo, I., Makles, A., Yuli, I., Dor, J., Blumberg, S., and Mashiach, S. (1994) Chemotaxis and chemokinesis of human spermatozoa to follicular factors, Biol. Reprod. 50, 774-785.
Rivkees, S.A., and Crawford, J.D. (1988) The relationship of gonadal activity and chemotherapy-induced gonadal damage, JAMA 259, 2123-2125.
Robboy, S.J., Szyfelbein, W.M., Goellner, J.R., Kaufman, R.H., Taft, P.D., Richart, R.M., Gaffey, T.A., Prat, J., Virata, R., Hatab, Pa., McGorray, S.P., Noller, K.L., Townsend, D., Labarthe, D., and Barnes, A.B. (1981) Dysplasia and cytologic findings in 4,589 young women enrolled in Diethylstilbestrol-Adenosis (DESAD) Project, Am. J. Obstet. Gynecol. 140, 579-586.
Roeser, H.P., Stocks, A.E., and Smith, A.J. (1978) Testicular damage due to cytotoxic drugs and recovery after cessation of therapy, Aust. N. Z. J. Med. 8, 250-254.
Schilsky, R.L., Lewis, B.J., Sherins, R.J., and Young, R.C. (1980) Gonadal dysfunction in patients receiving chemotherapy for cancer, Ann. Intern. Med.93, 109-114
Schuel, H., Burkman, L.J., Lippes, J., Crickard, K., Mahony, M.C., Giuffrida, A., Picone, R.P., and Makriyannis, A. (2002) Evidence that anandamide-signalling regulates human sperm functions required for fertilisation, Mol. Reprod. Dev. 63, 376-387.
Venn, A., Bruinsma, F., Werther, G., Pyett, P., Baird, D., Jones, P., Rayner, J., and Lumley, J. (2004) Oestrogen treatment to reduce the adult height of tall girls: long term effects on fertility, Lancet 364, 1513-1518.
Viviani, S., Ragni, G., Santoro, A., Perotti, L., Caccamo, E., Negretti, E., Valagussa, P., and Bonadonna, G. (1991) Testicular dysfunction in Hodgkin’s disease before and after treatment, Euro. J. Cancer. 27, 1389-1392.
Wagner, G., and Saenz de Tejada, I. (1998) Update on male erectile dysfunction, BMJ 316, 678-682.
Watkinson, G. (1986) Sulphasalazine: a review of 40 years’ experience, Drugs 32 Suppl 1, 1-11.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Pandiyan, N. (2007). Medical Drugs Impairing Fertility. In: Nicolopoulou-Stamati, P., Hens, L., Howard, C. (eds) Reproductive Health and the Environment. Environmental Science and Technology Library, vol 22. Springer, Dordrecht. https://doi.org/10.1007/1-4020-4829-7_9
Download citation
DOI: https://doi.org/10.1007/1-4020-4829-7_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-4828-9
Online ISBN: 978-1-4020-4829-6
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)